Efficacy of a Novel Procedure – FISH™

by Anthony A. Bavry

Multiple devices are currently available for closure of the femoral artery access site after cardiac catheterization. Currently, the most widely used closure devices are the Angio-Seal™ device (St. Jude Medical, St. Paul, Minnesota), and the Perclose® and StarClose™ (Abbott Vascular, Redwood City, California). The aim of these devices when compared to manual compression is to safely improve patient comfort, decrease time to hemostasis with earlier ambulation and expedited hospital discharge, thereby ultimately improving catheterization laboratory throughput.

There is evidence that these devices may also reduce vascular complications compared to manual hemostasis. Currently, no closure device is considered superior and universally utilized in achieving hemostasis compared to other closure devices or manual pressure.

The Femoral Introducer Sheath and Hemostasis, or FISH™ device (FISH, Morris Innovative, Inc. Bloomington, Indiana), is unique in that an extracellular matrix closure patch is premounted onto a 5, 6, 7 or 8 Fr access sheath.

This combines access and closure on the same device, with the potential for simplification of these two steps. The extracellular matrix patch may be important for tissue repair and remodeling.

Continue Reading the Article in The Journal of Invasive Cardiology >